Are you Dr. Kuo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 83 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 800-826-4673
Summary
- Dr. Phillip Kuo, MD is a board certified nuclear medicine physician in Duarte, California. He is currently licensed to practice medicine in California, Arizona, and Connecticut. He is affiliated with Banner - University Medical Center South.
Education & Training
Yale-New Haven Medical CenterResidency, Radiology-Diagnostic, 2005 - 2008
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Virginia School of MedicineClass of 2000
Certifications & Licensure
AZ State Medical License 2009 - 2027
CA State Medical License 2024 - 2026
CT State Medical License 2003 - 2010- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Nuclear Radiology
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
Clinical Trials
- Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma Start of enrollment: 2018 Apr 15
- Treatment of Post-Chemo Cognitive Impairment w/Transcranial Magnetic Stimulation (Chemobrain TMS) Start of enrollment: 2021 Mar 05
Publications & Presentations
PubMed
- Optimal DaTQUANT Thresholds for Diagnostic Accuracy of Dementia with Lewy Bodies (DLB) and Parkinson's Disease (PD).Phillip H Kuo, Patrick Cella, Ying-Hui Chou, Alexander Arkhipenko, Julia M Fisher
Tomography. 2024-10-09 - Survey of Clinical Protocols for the Use ofLu-PSMA-617 in the United States.Phillip H Kuo, Matthew F Covington, Daniel J Lee, Terence Z Wong, Neeta Pandit-Taskar
Journal of Nuclear Medicine Technology. 2024-09-05 - Interreader and Intrareader Reproducibility ofF-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3...Phillip H Kuo, Giuseppe Esposito, Gary A Ulaner, Don Yoo, Katherine Zukotynski
Journal of Nuclear Medicine. 2024-08-01
Press Mentions
PET Scans Predict Patient Response to PluvictoAugust 20th, 2024- Radionuclides That Target and Kill Advanced Prostate Cancer Cells Show Great PromiseSeptember 20th, 2022
- Imaging Criteria Helps Pick Best Patients for Pluvicto TreatmentMay 3rd, 2022
- Join now to see all
